Presenters
Consultant, Cardiac Positron Emission Tomography
Edward Bengie Magsombol, MD
Course Details
Hypertension is not just a number. As the initial step in the cardiovascular continuum, hypertension increases the risk of cardiovascular disease. During a webinar featuring Dr. Edward Bengie Magsombol (St. Luke’s Medical Center), he underscored the role of inhibition of the renin-angiotensin system in curbing hypertension and the clinical trials demonstrating the role of telmisartan in lowering blood pressure in mild to moderate hypertension and lowering cardiovascular risk.
Estimated Time of Completion: 33 mins and 02 sec.
Management of Hypertension Across the Full Patient Spectrum Course Outline
- Cardiovascular disease is a continuum
- Nonpharmacologic Interventions for all Patients with Hypertension
- Initial evaluation of newly diagnosed hypertension
- 2020 ISH Simplified Classification of Hypertension Risk
- KDIGO Heatmap
- Newly diagnosed hypertension: Low-risk
- ESC Guidelines 2018
- 2020 Philippine Hypertension CPG
- Causes of poor BP control
- Telmisartan: ARB developed by Boehringer Ingelheim
- Receptor binding affinity relative to half-life
- Effects of telmisartan in treatment-naice hypertensives
- Meta-analysis of telmisartan vcs losartan (Xi et al 2008)
- Telmisartan vs Losartan on Trough Ambulatory BP (18-24 Hours Post-Dosing)
- Meta-analysis of telmisartan vs losartan (Takagi et al 2013)
- Monotherapy is Inadequate in 40%-60% of Hypertensive Patients1
- AHA/ACC 2017 Guidelines
- Synergies of Counter-Regulation with ARB and D-CCB
- Enhanced Antihypertensive Efficacy
- Telmisartan Plus Amlodipine has a Safety and Tolerability Profile to Placebo
- Newly diagnosed hypertension: High-risk
- 2020 ISH Simplified Classification of Hypertension Risk
- 2020 Philippine Hypertension CPG
- High-risk Patients: Advantages of RAAS inhibitors
- Heart Outcomes Prevention Evaluation (HOPE) Study
- ONTARGET: Telmisartan is as Effective as Ramipril in Preventing CV Events at Increased CV Risk
- DM and HPN control both needed to prevent CKD
- 2002 Philippine CPG’s on Hypertension
- ZODIAC-14: ARB’s in Dutch T2DM Patients +/- HPN
- Comprehensive CV risk management
PC-PH-105713 | March 2024